Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for ATEC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -22.72M
March 31, 2026 -19.89M
December 31, 2025 -15.74M
September 30, 2025 -13.89M
June 30, 2025 -12.17M
March 31, 2025 -11.61M
December 31, 2024 -3.746M
September 30, 2024 -19.88M
June 30, 2024 -35.89M
March 31, 2024 -33.62M
December 31, 2023 -28.21M
September 30, 2023 -21.38M
June 30, 2023 -75.56M
March 31, 2023 -16.82M
December 31, 2022 -14.84M
September 30, 2022 -15.63M
June 30, 2022 -14.41M
March 31, 2022 -13.41M
December 31, 2021 -20.00M
September 30, 2021 -12.92M
June 30, 2021 -98.85M
March 31, 2021 -25.99M
December 31, 2020 -11.02M
September 30, 2020 -5.863M
June 30, 2020 -4.349M
Date Value
March 31, 2020 -2.629M
December 31, 2019 -2.595M
September 30, 2019 -6.72M
June 30, 2019 -2.649M
March 31, 2019 -1.068M
December 31, 2018 -3.467M
September 30, 2018 -1.819M
June 30, 2018 -2.301M
March 31, 2018 -14.08M
December 31, 2017 -0.179M
September 30, 2017 -0.968M
June 30, 2017 -3.371M
March 31, 2017 -1.977M
December 31, 2016 -1.96M
September 30, 2016 68.29M
June 30, 2016 -3.205M
March 31, 2016 -1.17M
December 31, 2015 -3.509M
September 30, 2015 -1.482M
June 30, 2015 -3.794M
March 31, 2015 -3.462M
December 31, 2014 -3.549M
September 30, 2014 -2.876M
June 30, 2014 -3.081M
March 31, 2014 -1.494M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Artivion, Inc. -129.41M
CONMED Corp. 11.57M
Integra LifeSciences Holdings Corp. -43.28M
Teleflex, Inc. -15.51M
Globus Medical, Inc. -129.05M